CN1742815A - External-use medicine of lysimachia root - Google Patents
External-use medicine of lysimachia root Download PDFInfo
- Publication number
- CN1742815A CN1742815A CN 200510106594 CN200510106594A CN1742815A CN 1742815 A CN1742815 A CN 1742815A CN 200510106594 CN200510106594 CN 200510106594 CN 200510106594 A CN200510106594 A CN 200510106594A CN 1742815 A CN1742815 A CN 1742815A
- Authority
- CN
- China
- Prior art keywords
- parts
- ramulus
- radix
- medicine
- folium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention discloses an antenoron filiforme root medicine for external application for effectively curing traumatic injuries, rheumatic sinew and bone pain, rheumatic arthritis and rheumatism, etc. Said medicine is made up by using 8 Chinese medicinal materials of antenoron filiforme root, dabogu, balengmu, bauhinia championi, schnabelia oligophylla and others and adding ethyl alcohol through a certain preparation process.
Description
Technical field:
The present invention relates to a kind of Radix Antenoronis Filiformis medicine for external use.
Background technology:
The traumatic injury disease is a kind of common disease, from ancient times to the present ill people is a lot, be subjected to ailing the torment, the various medicine for external use of Xiao Shouing are also a lot of in the market, slight illness for this quasi drugs treatment traumatic injury has played certain therapeutical effect really, but does not also have a kind of external specific drug of ideal treatment traumatic injury.
Summary of the invention:
The inventor is at above-mentioned weak point, and it is convenient to have a kind of treatment at patient's urgent needs, eutherapeutic medicine for external use; The inventor, verifies and by clinical trial repeatedly through research repeatedly, finally developed a kind of with low cost, prescription rationally, preparation is simple, very easy to use, compare with existing similar medicine for external use curative effect, better efficacy is a kind of medicine for external use of good traumatic injury.
Purpose of the present invention just provides a kind of Radix Antenoronis Filiformis medicine for external use.
Choice of drug Radix Antenoronis Filiformis of the present invention, Ramulus Et Folium Adhatodae Vasicae, Herba Saussuseae Japonicae, Caulis Bauhihiae Championii, Herba Schnabeliae Oligophyllae, Radix seu Folium Cinnamomi angustifolii, Rhizoma Panacis japonici, Ramulus Et Folium Adhatodae Ventricosea, ethanol (concentration is 35-75%) are formed; Wherein select Radix Antenoronis Filiformis for use: have eliminating stasis to stop pain, detumescence is invigorated blood circulation; Control traumatic injury, traumatic injury muscles and bones is hindered.Select Ramulus Et Folium Adhatodae Vasicae for use: have promoting blood circulation to remove blood stasis; Control traumatic injury, blood stasis swells and ache, rheumatic arthralgia.Select Herba Saussuseae Japonicae for use: have expelling wind and activating blood circulation; The dispelling the wind and dampness pathogens arthralgia pain, traumatic injury, rheumatic arthralgia.Select Caulis Bauhihiae Championii for use: have dispel the wind, blood stasis removing, pain relieving; Control traumatic injury, rheumatic ostalgia.Select Herba Schnabeliae Oligophyllae for use: have dispelling wind and removing obstruction in the collateral, eliminating stasis to stop pain; Control traumatic injury, rheumatic arthralgia, the rheumatic bones and muscles pain, lumbago is fallen the damage joint and is swollen and ache.Select Radix seu Folium Cinnamomi angustifolii for use: have relaxing muscles and tendons and activating QI and blood in the collateral, dispersing cold for relieving pain; Control traumatic injury, rheumatic arthralgia.Select Rhizoma Panacis japonici for use: have removing blood stasis and activating blood flow; Control traumatic injury, bones and muscles pain.Select Ramulus Et Folium Adhatodae Ventricosea for use: have removing blood stasis and activating blood flow, expelling wind and removing dampness; Control traumatic injury, osteopatia sprain, rheumatic arthritis.Make the effect of each medicine produce collaborative effect these drug regimens, thereby can realize effectively treating that traumatic injury, traumatic injury muscles and bones are hindered, blood stasis swells and ache, sprain swell and ache, traumatic injury stasis of blood pain, sprain fracture, rheumatism bones and muscles pain, muscles and bones are sprained pain, bones and tendons injury pain, traumatic hemorrhage, traumatic injury sprain and contusion wound, rheumatalgia, bones and muscles pain, osteopatia sprain, rheumatic ostalgia, soft tissue contusion, osteopatia sprain, rheumatic arthralgia, fall that the damage joint swells and ache, the disease of rheumatic arthritis, curative effect is illustrious.
The consumption of drug component of the present invention also is to carry out a large amount of solid lines through the inventor to grope to sum up and draw, and each amounts of components is for all to have better therapeutic effect in the following weight parts scope; It is made up of the component of following parts by weight:
Radix Antenoronis Filiformis 1-12 part, Ramulus Et Folium Adhatodae Vasicae 1-10 part, Herba Saussuseae Japonicae 1-14 part, Caulis Bauhihiae Championii 1-10 part, Herba Schnabeliae Oligophyllae 1-14 part, Radix seu Folium Cinnamomi angustifolii 1-7 part, Rhizoma Panacis japonici 1-7 part, Ramulus Et Folium Adhatodae Ventricosea 1-14 part, ethanol (concentration is 35-75%) 32-352 part.
Optimization formula of the present invention is:
9 parts of Radix Antenoronis Filiformiss, 7 parts of Ramulus Et Folium Adhatodae Vasicae, 11 parts of Herba Saussuseae Japonicaes, 7 parts of Caulis Bauhihiae Championiis, 11 parts of Herba Schnabeliae Oligophyllaes, 4 parts of Radix seu Folium Cinnamomi angustifolii, 4 parts of Rhizoma Panacis japonici, 11 parts of Ramulus Et Folium Adhatodae Ventricosea, 256 parts of ethanol (concentration is 35-75%).
A kind of Radix Antenoronis Filiformis medicine for external use of the present invention has relaxing muscles and tendons and activating QI and blood in the collateral, promoting blood circulation to remove blood stasis, an effect of the analgesia of dispeling the wind; Be a kind of with low cost, prescription rationally, preparation is simple, easy to use, compares with existing similar medicine for external use curative effect, Radix Antenoronis Filiformis medicine for external use curative effect is fine.Radix Antenoronis Filiformis medicine for external use of the present invention was once done a large amount of clinical trials in early stage, give on the patient treatment case surplus in the of tens example time, comprise be used for the treatment of that traumatic injury, traumatic injury muscles and bones are hindered, blood stasis swells and ache, sprain swell and ache, traumatic injury stasis of blood pain, sprain fracture, rheumatism bones and muscles pain, muscles and bones are sprained pain, bones and tendons injury pain, traumatic hemorrhage, traumatic injury sprain and contusion wound, rheumatalgia, bones and muscles pain, osteopatia sprain, rheumatic ostalgia, soft tissue contusion, osteopatia sprain, rheumatic arthralgia, fall that the damage joint swells and ache, the disease of rheumatic arthritis, do not see untoward reaction during the treatment.Total effective rate is more than 87%, and curative effect is illustrious.
Using method:
This medicine is a medicine for external use, and oral administration is at first cleaned the affected part with hot water, will dab in the affected part with the drenched medicinal liquid of absorbent cotton, and be good with palm of the hand stranding or the heating of tip-tap affected part, every day 3-6 time.
The specific embodiment:
Describe embodiments of the invention below in detail:
Embodiment 1:
A kind of Radix Antenoronis Filiformis medicine for external use provided by the present invention is made up of the component of following parts by weight; Radix Antenoronis Filiformis 1-12 part, Ramulus Et Folium Adhatodae Vasicae 1-10 part, Herba Saussuseae Japonicae 1-14 part, Caulis Bauhihiae Championii 1-10 part, Herba Schnabeliae Oligophyllae 1-14 part, Radix seu Folium Cinnamomi angustifolii 1-7 part, Rhizoma Panacis japonici 1-7 part, Ramulus Et Folium Adhatodae Ventricosea 1-14 part, ethanol (concentration is 35-75%) 32-352 part.
Embodiment 2:
Optimization formula of the present invention is:
9 parts of Radix Antenoronis Filiformiss, 7 parts of Ramulus Et Folium Adhatodae Vasicae, 11 parts of Herba Saussuseae Japonicaes, 7 parts of Caulis Bauhihiae Championiis, 11 parts of Herba Schnabeliae Oligophyllaes, 4 parts of Radix seu Folium Cinnamomi angustifolii, 4 parts of Rhizoma Panacis japonici, 11 parts of Ramulus Et Folium Adhatodae Ventricosea, 256 parts of ethanol (concentration is 35-75%).
Preparation method of the present invention is: at first with above-mentioned Radix Antenoronis Filiformis, Ramulus Et Folium Adhatodae Vasicae, Herba Saussuseae Japonicae, Caulis Bauhihiae Championii, Herba Schnabeliae Oligophyllae, Radix seu Folium Cinnamomi angustifolii, Rhizoma Panacis japonici, Ramulus Et Folium Adhatodae Ventricosea, the single short fragment that is cut into respectively, each single short fragment that is cut into is mixed in proportion together, be placed in the container then, and allocate ethanol (concentration is 35-75%) into, stir the back sealed container in, according to the modern Chinese medicine processing technology or after soaking 10-15 days, the mixture solution after handling packed into by the required metering of client to get product in the bottle.
Claims (3)
1, a kind of Radix Antenoronis Filiformis medicine for external use is characterized in that: Radix Antenoronis Filiformis, Ramulus Et Folium Adhatodae Vasicae, Herba Saussuseae Japonicae, Caulis Bauhihiae Championii, Herba Schnabeliae Oligophyllae, Radix seu Folium Cinnamomi angustifolii, Rhizoma Panacis japonici, Ramulus Et Folium Adhatodae Ventricosea, ethanol (concentration is 35-75%).
2, a kind of Radix Antenoronis Filiformis medicine for external use according to claim 1, it is characterized in that: the component by following parts by weight is formed; Radix Antenoronis Filiformis 1-12 part, Ramulus Et Folium Adhatodae Vasicae 1-10 part, Herba Saussuseae Japonicae 1-14 part, Caulis Bauhihiae Championii 1-10 part, Herba Schnabeliae Oligophyllae 1-14 part, Radix seu Folium Cinnamomi angustifolii 1-7 part, Rhizoma Panacis japonici 1-7 part, Ramulus Et Folium Adhatodae Ventricosea 1-14 part, ethanol 32-352 part.
3, a kind of Radix Antenoronis Filiformis medicine for external use according to claim 1, it is characterized in that: the component by following parts by weight is formed; 9 parts of Radix Antenoronis Filiformiss, 7 parts of Ramulus Et Folium Adhatodae Vasicae, 11 parts of Herba Saussuseae Japonicaes, 7 parts of Caulis Bauhihiae Championiis, 11 parts of Herba Schnabeliae Oligophyllaes, 4 parts of Radix seu Folium Cinnamomi angustifolii, 4 parts of Rhizoma Panacis japonici, 11 parts of Ramulus Et Folium Adhatodae Ventricosea, 256 parts of ethanol.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510106594 CN1742815A (en) | 2005-10-07 | 2005-10-07 | External-use medicine of lysimachia root |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510106594 CN1742815A (en) | 2005-10-07 | 2005-10-07 | External-use medicine of lysimachia root |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1742815A true CN1742815A (en) | 2006-03-08 |
Family
ID=36138440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510106594 Pending CN1742815A (en) | 2005-10-07 | 2005-10-07 | External-use medicine of lysimachia root |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1742815A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105456723A (en) * | 2015-12-31 | 2016-04-06 | 刘婵琳 | Traditional Chinese medicine ointment for treating gynecological bone fractures |
-
2005
- 2005-10-07 CN CN 200510106594 patent/CN1742815A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105456723A (en) * | 2015-12-31 | 2016-04-06 | 刘婵琳 | Traditional Chinese medicine ointment for treating gynecological bone fractures |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1742895A (en) | External-use medicine of Herba sarcandrae | |
| CN1742816A (en) | Wujiaofeng root external-use medicine | |
| CN1814010A (en) | Japanese supplejack collateral-flow-activating pain-relieving medicine | |
| CN1813952A (en) | Medicine of yellow cinnamon root for activating collaterals | |
| CN1813944A (en) | External-use drug of securidaca inappendiculata hassk for traumatic injury and activating collaterals | |
| CN1742815A (en) | External-use medicine of lysimachia root | |
| CN1742801A (en) | Qianjinba external-use medicine | |
| CN1762469A (en) | Externally applied medicine of madeira vine | |
| CN1813898A (en) | External-use medicine of hayberry bark for traumatic injury and activating collaterals | |
| CN1814069A (en) | Collateral-flow-activating pain-relieving medicine of Herba Antenori Filliformis root | |
| CN1739693A (en) | Externally applied medicine of dunn tongoloa root | |
| CN1814066A (en) | Collateral-flow-activating pain-relieving medicine of caulis et Folium Trachelospermi | |
| CN1739740A (en) | Externally applied medicine of fewleaf schnabelia herb | |
| CN1742907A (en) | External-use medicine of Radix celastri orbiculati | |
| CN1742839A (en) | Nutritious health-care oral liquor for woman and preparing process | |
| CN1762436A (en) | Externally applied medicine of Ligularia lapathifolia | |
| CN1762479A (en) | Externally applied medicine of stahlianthus involucratus | |
| CN1742857A (en) | Berchemia sinica schneid external-use medicine | |
| CN1739726A (en) | Externally applied medicine of champion bauhinia stem | |
| CN1742972A (en) | External-use medicine of Herba chloranthi multistachydis | |
| CN1813963A (en) | External medicine of Herbaet Rhizoma Begoniae cavalerei for treating traumatic injuries and activating collateral flows | |
| CN1742856A (en) | Radix aconitic kusnezoffii external-use medicine | |
| CN1742961A (en) | External-use medicine of Rhizome cyperi | |
| CN1814103A (en) | Collateral-flow-activating pain-relieving medicine of Radix Ardisiae crenatae | |
| CN1813951A (en) | Medicine of acuonitum brachaypodum diels for activating collaterals and stopping pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |